Sign Up Today and Learn More About Oblenio Bio Stock
Invest in or calculate the value of your shares in Oblenio Bio or other pre-IPO companies through EquityZen's platform.
Oblenio Bio Stock
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
About Oblenio Bio Stock
Founded
2024
Headquarters
Oakland, CA, US
Industries
Apps, Artificial Intelligence, Software
Oblenio Bio Press Mentions
Stay in the know about the latest news on Oblenio Bio
Oblenio Bio Raises $62 Million Series B To Advance Autoimmune Disease Therapy
pulse2 • Jun 28, 2026
Oblenio’s $62M series B for trispecific antibody in autoimmune diseases
bioworld • Jun 26, 2026
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
vcaonline • Jun 26, 2026
Oblenio Bio Closes $62M Series B Funding
finsmes • Jun 25, 2026
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
biospace • Jun 25, 2026
Join now and verify your accreditation status to gain access to:
- Oblenio Bio Current Valuation
- Oblenio Bio Stock Price
- Oblenio Bio Management
- Available deals in Oblenio Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Oblenio Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Oblenio Bio Revenue and Financials
- Oblenio Bio Highlights
- Oblenio Bio Business Model
- Oblenio Bio Risk Factors
- Oblenio Bio Research Report from SACRA Research
Trading Oblenio Bio Stock
How to invest in Oblenio Bio stock?
Accredited investors can buy pre-IPO stock in companies like Oblenio Bio through EquityZen funds. These investments are made available by existing Oblenio Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Oblenio Bio stock?
Shareholders can sell their Oblenio Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."